 "Kamala Harris says she would not trust Trump alone on coronavirus vaccine")
Democratic Vice Presidential nominee Kamala Harris on Saturday (local time) said that she would not trust Donald Trump alone on a coronavirus vaccine adding that it would have to be a "credible source" that talks about "the efficacy and the reliability of whatever he's talking about".
In an interview with CNN, Harris said that it was "going to be an issue for all of us" to get a vaccine that was approved and distributed before the presidential elections.
"I will say that I would not trust Donald Trump and it would have to be a credible source of information that talks about the efficacy and the reliability of whatever he's talking about. I would not take his word," CNN reported quoting Harris.
The California Senator further said that public health experts would be "suppressed, sidelined" with regard to getting the last word on the efficacy of the vaccine.
"If past is the prologue that they will not, they'll be muzzled, they'll be suppressed, they will be sidelined because he's looking at an election coming up in less than 60 days and he's grasping to get whatever he can to pretend he has been a leader on this issue when he is not."
As per the latest update, the US has a total of 6,232,889 COVID-19 cases and 188,252 deaths due to the coronavirus, according to Johns Hopkins University.
The Presidential elections are scheduled to be held on November 3.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app